Occurrence of adverse reactions after vaccination. within 7 days after the vaccination [clinicaltrials_resource:a86d54004c60be7d3dc82f12246a0abb]

Occurrence of adverse reactions after vaccination. within 7 days after the vaccination [clinicaltrials_resource:a86d54004c60be7d3dc82f12246a0abb]

Occurrence of adverse reactions within 7 days after vaccination with the Ebola Zaire vaccine (Ad5-EBOV).
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Secondary outcome [clinicaltrials_vocabulary:secondary-outcome]
http://bio2rdf.org/clinicaltrials_resource:a86d54004c60be7d3dc82f12246a0abb
A Phase I Clinical Trial to Evaluate the Ebola Adenovirus Vector Vaccine (Ad5-EBOV) in Healthy Adults. [clinicaltrials:NCT02326194]
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]

Occurrence of adverse reactions after vaccination. within 7 days after the vaccination [clinicaltrials_resource:a86d54004c60be7d3dc82f12246a0abb]

Occurrence of adverse reactions within 7 days after vaccination with the Ebola Zaire vaccine (Ad5-EBOV).
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Secondary outcome [clinicaltrials_vocabulary:secondary-outcome]
http://bio2rdf.org/clinicaltrials_resource:a86d54004c60be7d3dc82f12246a0abb
Bio2RDF identifier
a86d54004c60be7d3dc82f12246a0abb
Bio2RDF namespace
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:a86d54004c60be7d3dc82f12246a0abb
measure [clinicaltrials_vocabulary:measure]
Occurrence of adverse reactions after vaccination.
time frame [clinicaltrials_vocabulary:time-frame]
within 7 days after the vaccination
description
Occurrence of adverse reaction ...... bola Zaire vaccine (Ad5-EBOV).
identifier
clinicaltrials_resource:a86d54004c60be7d3dc82f12246a0abb
title
Occurrence of adverse reactions after vaccination. within 7 days after the vaccination
@en
inDataset
type
label
Occurrence of adverse reaction ...... d54004c60be7d3dc82f12246a0abb]
@en